Hapvida Participações e Investimentos Dividendo

Dividendo criteri di controllo 0/6

Hapvida Participações e Investimentos non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	2.0%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	-R$0.074
Previsione del rendimento del dividendo	2.4%

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet

Jul 16

Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing

Apr 28

Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?

Mar 28

Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)

Jan 07

Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt

Dec 11

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Sep 11

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Jun 08

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt

Feb 27

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet

Nov 11

At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?

Sep 11

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden

Jul 08

Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?

Mar 27

We Think Hapvida Participações e Investimentos (BVMF:HAPV3) Is Taking Some Risk With Its Debt

Dec 28

Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?

Nov 23

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Sep 10

Should You Think About Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Now?

Aug 06

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

May 12

The Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Annual Results Are Out And Analysts Have Published New Forecasts

Mar 20

Introducing Hapvida Participações e Investimentos (BVMF:HAPV3), A Stock That Climbed 55% In The Last Year

Mar 10

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet

Feb 11

Is Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 07

Investors Who Bought Hapvida Participações e Investimentos (BVMF:HAPV3) Shares A Year Ago Are Now Up 34%

Dec 10

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di HAPV3 siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di HAPV3 siano aumentati.

Rendimento dei dividendi rispetto al mercato

Hapvida Participações e Investimentos Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di HAPV3 rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (HAPV3)	n/a
Fondo del 25% del mercato (BR)	2.7%
Top 25% del mercato (BR)	9.7%
Media del settore (Healthcare)	2.0%
Analista previsionale (HAPV3) (fino a 3 anni)	2.4%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di HAPV3 rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di HAPV3 rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di HAPV3 per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché HAPV3 non ha segnalato alcun pagamento.

Hapvida Participações e Investimentos Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

Now 20% undervalued

Second quarter 2024 earnings: Revenues in line with analyst expectations

Now 20% undervalued

Price target increased by 23% to R$7.26

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet

First quarter 2024 earnings: EPS exceeds analyst expectations

Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing

Full year 2023 earnings: EPS misses analyst expectations

Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?

Hapvida Participações e Investimentos S.A., Annual General Meeting, Apr 30, 2024

Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)

Hapvida Participações e Investimentos S.A.(BOVESPA:HAPV3) dropped from Brazil Valor BM&FBOVESPA Index

Hapvida Participações e Investimentos S.A. to Report Q3, 2024 Results on Nov 07, 2024

Hapvida Participações e Investimentos S.A. to Report Q1, 2024 Results on May 09, 2024

Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt

Second quarter 2023 earnings released: R$0.02 loss per share (vs R$0.05 loss in 2Q 2022)

Consensus EPS estimates fall by 24%

New minor risk - Share price stability

Consensus EPS estimates fall by 11%

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Consensus EPS estimates upgraded to R$0.087 loss

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: R$0.02 loss per share (vs R$0.05 loss in 2Q 2022)

Consensus EPS estimates fall by 20%

Consensus EPS estimates upgraded to R$0.064 loss

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Consensus EPS estimates upgraded to R$0.072 loss

Price target increased by 8.8% to R$4.72

High number of new directors

Consensus EPS estimates upgraded to R$0.10 loss

Consensus EPS estimates fall by 46%

First quarter 2023 earnings released

Price target decreased by 12% to R$4.70

Price target decreased by 7.3% to R$5.37

Consensus EPS estimates fall by 13%

Consensus EPS estimates fall by 370%

Price target decreased by 10% to R$5.79

Now 42% undervalued after recent price drop

Price target decreased by 11% to R$6.45

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt

Consensus EPS estimates upgraded to R$0.089 loss

Hapvida Participações e Investimentos S.A., Annual General Meeting, Apr 27, 2023

Price target decreased to R$8.90

Price target decreased to R$9.32

Now 20% undervalued after recent price drop

Hapvida Participações e Investimentos S.A. to Report Q3, 2023 Results on Nov 08, 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Third quarter 2022 earnings: Revenues miss analyst expectations

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet

Hapvida Participações e Investimentos S.A. (BOVESPA:HAPV3) acquired SISTEMAS E PLANOS DE SAUDE LTDA for BRL 120 million.

Price target increased to R$10.73

At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus forecasts updated

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden

Consensus EPS estimates fall by 15%

Price target decreased to R$12.32

Price target decreased to R$12.90

Price target decreased to R$13.40

Consensus EPS estimates fall by 10%

Consensus forecasts updated

Consensus forecasts updated

Less than half of directors are independent

Now 23% undervalued

Hapvida Participações e Investimentos S.A., Annual General Meeting, Apr 25, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?

We Think Hapvida Participações e Investimentos (BVMF:HAPV3) Is Taking Some Risk With Its Debt

Hapvida Participações e Investimentos S.A. (BOVESPA:HAPV3) acquired a 73% stake in Hospital Otaviano Neves for BRL 150 million.

Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Hapvida Participações e Investimentos S.A. (BOVESPA:HAPV3) agreed to acquire a 94.34% stake in Sociedade Hospitalar de Uberlândia S/A for BRL 120 million.